about
Effect of a low-flatulogenic diet in patients with flatulence and functional digestive symptoms.Digestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome: Validation of Symptom Frequency Questionnaire.The Intestinal Gas Questionnaire: development of a new instrument for measuring gas-related symptoms and their impact on daily life.Intestinal gas content and distribution in health and in patients with functional gut symptoms.Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome.Accumulative effect of food residues on intestinal gas production.Effect of selective CCK1 receptor antagonism on accommodation and tolerance of intestinal gas in functional gut disorders.Processing faecal samples: a step forward for standards in microbial community analysis[Prebiotics: concept, properties and beneficial effects].Assessment of rectocolonic morphology and function in patients with Chagas disease in Barcelona (Spain).High Resolution Esophageal Manometry in Patients with Chagas Disease: A Cross-Sectional Evaluation.MetaTrans: an open-source pipeline for metatranscriptomics.Motility bar: A new tool for motility analysis of endoluminal videos.Education of the postprandial experience by a sensory-cognitive intervention.Diabetic neuropathy in the gut: pathogenesis and diagnosis.Bloating and Abdominal Distension: Old Misconceptions and Current Knowledge.High-resolution manometry in patients with idiopathic inflammatory myopathy: Elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset.Brain networks associated with cognitive and hedonic responses to a meal.miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea.Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function.Intestinal gas homeostasis: disposal pathways.Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study.Colonic content: effect of diet, meals, and defecation.Nitrergic and purinergic mechanisms evoke inhibitory neuromuscular transmission in the human small intestine.Classification of functional bowel disorders by objective physiological criteria based on endoluminal image analysis.Metabolic adaptation of colonic microbiota to galactooligosaccharides: a proof-of-concept-study.Relation between cognitive and hedonic responses to a meal.Incongruence between Clinicians' Assessment and Self-Reported Functioning Is Related to Psychopathology among Patients Diagnosed with Gastrointestinal Disorders.Effects of meal palatability on postprandial sensations.Correction of Abdominal Distention by Biofeedback-Guided Control of Abdominothoracic Muscular Activity in a Randomized, Placebo-Controlled Trial.Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study.Decreased TESK1-mediated cofilin 1 phosphorylation in the jejunum of IBS-D patients may explain increased female predisposition to epithelial dysfunction.Biogastronomy: Factors that determine the biological response to meal ingestion.Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations.Colonic gas homeostasis: Mechanisms of adaptation following HOST-G904 galactooligosaccharide use in humans.Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome.Comparison between small bowel manometric patterns and full-thickness biopsy histopathology in severe intestinal dysmotility.Appetite influences the responses to meal ingestion.Effect of prucalopride on intestinal gas tolerance in patients with functional bowel disorders and constipation.Cognitive and hedonic responses to meal ingestion correlate with changes in circulating metabolites.
P50
Q33460827-C7C24C4C-56DF-404A-B0C2-3540081E6AB5Q33462226-457C4A59-4A69-44A5-B412-905A4B2985C3Q33464699-43957DF9-0485-4273-B756-C4E1E60808C0Q33465395-6F8DD6E0-92BB-4173-B5BB-1818EE008FAEQ33465766-FACD6B09-B5AF-48C2-A890-3DD2B58C8CC1Q33465890-0C9F72FA-1D43-4DF9-9C5B-A0F743032886Q33466223-3E2085C1-BA7C-4A12-B20B-386DF2C7DC02Q33611925-B348F94D-97AE-4849-A657-A1F031567F8BQ35557133-F60AD519-7D12-4CA3-B34E-A87EC8B9EAE1Q35590724-5DEC50C1-57F5-4100-8D57-E41283D02925Q35915569-054D09C7-B7B1-4440-AD97-A8E261897C58Q36925280-169570A2-B235-4B42-80CD-28D28FE0372AQ38442244-4298194D-90D4-47E3-B675-C38A6D771DE1Q38610611-ACCE1825-0C10-4050-8A25-38CD1D3A6D3EQ38661634-2A4BB1E9-E35B-4FF9-A767-B2E3EDE57F2AQ38783848-43E625F0-A3CC-4758-A24D-63F9B7C663FAQ39116064-EB3DD1EF-BB83-46ED-B06B-01EB8668B63BQ39302678-4907215D-50F4-47BC-A09B-3D7987F6C71EQ40373925-5F7B8E12-D2BC-48CE-8D1F-FB97AC6A6B9BQ40949714-012494C9-B168-4173-8E0B-008373926450Q41593277-97EC3A22-FC6F-43A1-B8AB-B1EB1F1B07CDQ42284204-AF946D78-0481-4524-8708-8D4E256C743FQ43353481-D501D402-8FD8-4F4E-BBBC-70C8DB5BC8E9Q44221243-FC3F1C59-9F9C-48AF-B53D-9854CE7CD85DQ45953777-700A6820-965C-4846-A05C-F3D972CE8F78Q46433704-FCFACABD-419C-459B-8DE9-B1ACBABC7940Q47356970-5CD76D85-C5AC-48C9-AA11-FDFCB42DE89BQ47426594-4E526BD7-0F26-440D-8FFD-857AAA4CF332Q47653483-996A8AD9-C54D-4236-BB84-892DD3538CDEQ47834264-6B43BDFE-FC9F-48D4-BE8C-F4174C4D8A3AQ48046826-4A61AEC9-75FC-438A-8A77-8A9205639D19Q48112942-2D41F51C-77C2-4E82-B24C-37625BE2EFE2Q48117444-E625C3DD-44F7-4071-940A-28FD795518B8Q48215859-FAF495BD-A45F-44BB-8ED6-2584AC305A7AQ48266107-E74F475E-F689-4453-8D81-D85967BD3365Q48274669-8CDF7EAF-48B6-4320-9B9C-94BBDD684087Q48302010-D2FF4055-9878-4A93-AA15-F7AED2424737Q48330507-1D762F21-69FD-4093-8D14-1E49CC44227AQ48350930-EBFF936B-3C3A-4D91-86E6-66DC064D96B0Q50238174-2C5E3A82-AFA1-4163-AC1F-18F34DE235D2
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fernando Azpiroz
@ast
Fernando Azpiroz
@en
Fernando Azpiroz
@es
Fernando Azpiroz
@nl
Fernando Azpiroz
@sl
type
label
Fernando Azpiroz
@ast
Fernando Azpiroz
@en
Fernando Azpiroz
@es
Fernando Azpiroz
@nl
Fernando Azpiroz
@sl
prefLabel
Fernando Azpiroz
@ast
Fernando Azpiroz
@en
Fernando Azpiroz
@es
Fernando Azpiroz
@nl
Fernando Azpiroz
@sl
P106
P21
P31
P496
0000-0002-7327-960X